| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma
|
Nie, Pei
|
|
|
48 |
1 |
p. 217-230
|
article
|
| 2 |
A microdose clinical trial to evaluate [18F]Florastamin as a positron emission tomography imaging agent in patients with prostate cancer
|
Lee, Inki
|
|
|
48 |
1 |
p. 95-102
|
article
|
| 3 |
Application of 18F-FDG PET/CT in necrobiotic xanthogranuloma involving multiple organs
|
Hou, JiaLe
|
|
|
48 |
1 |
p. 321-322
|
article
|
| 4 |
A prospective intra-individual comparison of [68Ga]Ga-PSMA-11 PET/CT, [68Ga]Ga-NODAGAZOL PET/CT, and [99mTc]Tc-MDP bone scintigraphy for radionuclide imaging of prostate cancer skeletal metastases
|
Lawal, Ismaheel O.
|
|
|
48 |
1 |
p. 134-142
|
article
|
| 5 |
Augmented deep learning model for improved quantitative accuracy of MR-based PET attenuation correction in PSMA PET-MRI prostate imaging
|
Pozaruk, Andrii
|
|
|
48 |
1 |
p. 9-20
|
article
|
| 6 |
Clinical outcome of PSMA-guided radiotherapy for patients with oligorecurrent prostate cancer
|
Stefan A. Koerber,
|
|
|
48 |
1 |
p. 143-151
|
article
|
| 7 |
Clinical response assessment on DW-MRI compared with FDG-PET/CT after neoadjuvant chemoradiotherapy in patients with oesophageal cancer
|
Vollenbrock, Sophie E.
|
|
|
48 |
1 |
p. 176-185
|
article
|
| 8 |
Clinical value of negative 68Ga-PSMA PET/CT in the management of biochemical recurrent prostate cancer patients
|
Celli, M
|
|
|
48 |
1 |
p. 87-94
|
article
|
| 9 |
Correction to: Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma
|
Nie, Pei
|
|
|
48 |
1 |
p. 325-327
|
article
|
| 10 |
COVID-19 in the act: incidental 18F-FDG PET/CT findings in asymptomatic patients and those with symptoms not primarily correlated with COVID-19 during the United Kingdom coronavirus lockdown
|
Halsey, Richard
|
|
|
48 |
1 |
p. 269-281
|
article
|
| 11 |
COVID-19 pneumonia: relationship between inflammation assessed by whole-body FDG PET/CT and short-term clinical outcome
|
Dietz, Matthieu
|
|
|
48 |
1 |
p. 260-268
|
article
|
| 12 |
CT abnormalities evocative of lung infection are associated with lower 18F-FDG uptake in confirmed COVID-19 patients
|
Bahloul, Achraf
|
|
|
48 |
1 |
p. 282-286
|
article
|
| 13 |
CT protocol optimisation in PET/CT: what we learn from a systematic review
|
Bertolini, V.
|
|
|
48 |
1 |
p. 1-2
|
article
|
| 14 |
Defining a Centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [18F] flutemetamol amyloid PET study
|
Hanseeuw, Bernard J.
|
|
|
48 |
1 |
p. 302-310
|
article
|
| 15 |
Diagnostic accuracy of FDG-PET/MRI versus pelvic MRI and thoracic and abdominal CT for detecting synchronous distant metastases in rectal cancer patients
|
Queiroz, Marcelo A.
|
|
|
48 |
1 |
p. 186-195
|
article
|
| 16 |
EANM position paper on article 56 of the Council Directive 2013/59/Euratom (basic safety standards) for nuclear medicine therapy
|
Konijnenberg, Mark
|
|
|
48 |
1 |
p. 67-72
|
article
|
| 17 |
Efficacy of delayed 18F-FDG hybrid PET/MRI for epileptic focus identification: a prospective cohort study
|
Liu, Fang
|
|
|
48 |
1 |
p. 293-301
|
article
|
| 18 |
18F-FDG PET/CT of multiple cavitating pulmonary squamous cell carcinoma
|
Li, Weilong
|
|
|
48 |
1 |
p. 318-320
|
article
|
| 19 |
Fibroblast imaging of hepatic carcinoma with 68Ga-FAPI-04 PET/CT: a pilot study in patients with suspected hepatic nodules
|
Shi, Ximin
|
|
|
48 |
1 |
p. 196-203
|
article
|
| 20 |
First patient exceeding 5-year complete remission after 225Ac-PSMA-TAT
|
Rathke, Hendrik
|
|
|
48 |
1 |
p. 311-312
|
article
|
| 21 |
[68Ga]Ga-DOTA-TOC PET/CT fused to MRI in post-operative evaluation of olfactory groove meningioma: a case on millimetric remnants
|
Salgues, B.
|
|
|
48 |
1 |
p. 316-317
|
article
|
| 22 |
Gallbladder malakoplakia masquerading as malignant primary on 18F-FDG PET/CT
|
Bedmutha, Akshay Sharad
|
|
|
48 |
1 |
p. 323-324
|
article
|
| 23 |
Imaging assisted evaluation of antitumor efficacy of a new histone deacetylase inhibitor in the castration-resistant prostate cancer
|
Chen, Zude
|
|
|
48 |
1 |
p. 53-66
|
article
|
| 24 |
Impact of forced diuresis with furosemide and hydration on the halo artefact and intensity of tracer accumulation in the urinary bladder and kidneys on [68Ga]Ga-PSMA-11-PET/CT in the evaluation of prostate cancer patients
|
Uprimny, Christian
|
|
|
48 |
1 |
p. 123-133
|
article
|
| 25 |
Impact of 68Ga-NOTA-MAL-MZHER2 PET imaging in advanced gastric cancer patients and therapeutic response monitoring
|
Zhou, Nina
|
|
|
48 |
1 |
p. 161-175
|
article
|
| 26 |
Improved resolution and sensitivity of [18F]MFBG PET compared with [123I]MIBG SPECT in a patient with a norepinephrine transporter–expressing tumour
|
Pauwels, Elin
|
|
|
48 |
1 |
p. 313-315
|
article
|
| 27 |
Incidental findings suggestive of COVID-19 in asymptomatic cancer patients undergoing 18F-FDG PET/CT in a low prevalence region
|
Pallardy, Amandine
|
|
|
48 |
1 |
p. 287-292
|
article
|
| 28 |
In vivo imaging of CNS microglial activation/macrophage infiltration with combined [18F]DPA-714-PET and SPIO-MRI in a mouse model of relapsing remitting experimental autoimmune encephalomyelitis
|
Coda, A. R.
|
|
|
48 |
1 |
p. 40-52
|
article
|
| 29 |
Kinetic modeling and parametric imaging with dynamic PET for oncological applications: general considerations, current clinical applications, and future perspectives
|
Dimitrakopoulou-Strauss, Antonia
|
|
|
48 |
1 |
p. 21-39
|
article
|
| 30 |
177Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective study
|
Paganelli, Giovanni
|
|
|
48 |
1 |
p. 152-160
|
article
|
| 31 |
Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial)
|
Ahmadzadehfar, Hojjat
|
|
|
48 |
1 |
p. 113-122
|
article
|
| 32 |
Radiological protection and biological COVID-19 protection in the nuclear medicine department
|
Ohnuki, Kazunobu
|
|
|
48 |
1 |
p. 6-8
|
article
|
| 33 |
Response and outcome of liver metastases in patients with metastatic castration-resistant prostate cancer (mCRPC) undergoing 177Lu-PSMA-617 radioligand therapy
|
Khreish, Fadi
|
|
|
48 |
1 |
p. 103-112
|
article
|
| 34 |
Theranostic implications of molecular imaging phenotype of well-differentiated pulmonary carcinoid based on 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT
|
Zidan, Lamiaa
|
|
|
48 |
1 |
p. 204-216
|
article
|
| 35 |
The use of a visual 4-point scoring scale improves the yield of 18F-FDG PET-CT imaging in the diagnosis of renal and hepatic cyst infection in patients with autosomal dominant polycystic kidney disease
|
Neuville, Marie F.
|
|
|
48 |
1 |
p. 254-259
|
article
|
| 36 |
The value of 18F-FDG PET/CT for the diagnosis of device-related infections in patients with a left ventricular assist device: a systematic review and meta-analysis
|
ten Hove, D.
|
|
|
48 |
1 |
p. 241-253
|
article
|
| 37 |
To what extent has the reorganization of nuclear medicine activities during the COVID-19 pandemic fulfilled medical ethics?
|
Gonzalez, Sandra
|
|
|
48 |
1 |
p. 3-5
|
article
|
| 38 |
Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings
|
Chen, Haojun
|
|
|
48 |
1 |
p. 73-86
|
article
|
| 39 |
Value of 18F-FDG PET/CT radiomic features to distinguish solitary lung adenocarcinoma from tuberculosis
|
Hu, Yujing
|
|
|
48 |
1 |
p. 231-240
|
article
|
Journal description